FI116120B - Uusi menetelmä suun kautta annettavien, syklosporiinia sisältävien farmaseuttisten valmisteiden valmistamiseksi - Google Patents

Uusi menetelmä suun kautta annettavien, syklosporiinia sisältävien farmaseuttisten valmisteiden valmistamiseksi Download PDF

Info

Publication number
FI116120B
FI116120B FI954986A FI954986A FI116120B FI 116120 B FI116120 B FI 116120B FI 954986 A FI954986 A FI 954986A FI 954986 A FI954986 A FI 954986A FI 116120 B FI116120 B FI 116120B
Authority
FI
Finland
Prior art keywords
cyclosporin
preparation
alkylene
active ingredient
component
Prior art date
Application number
FI954986A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954986A (fi
FI954986A0 (fi
Inventor
Monika Petszulat
Klaus Neuer
Hatto Walch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25925049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI116120(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4412201A external-priority patent/DE4412201A1/de
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI954986A publication Critical patent/FI954986A/fi
Publication of FI954986A0 publication Critical patent/FI954986A0/fi
Application granted granted Critical
Publication of FI116120B publication Critical patent/FI116120B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FI954986A 1993-04-20 1995-10-19 Uusi menetelmä suun kautta annettavien, syklosporiinia sisältävien farmaseuttisten valmisteiden valmistamiseksi FI116120B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4312728 1993-04-20
DE4312728 1993-04-20
DE4412201A DE4412201A1 (de) 1993-04-20 1994-04-08 Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
DE4412201 1994-04-08
PCT/EP1994/001228 WO1994023733A1 (de) 1993-04-20 1994-04-20 Neue pharmazeutische zubereitungen zur oralen verabreichung enthaltend cyclosporin
EP9401228 1994-04-20

Publications (3)

Publication Number Publication Date
FI954986A FI954986A (fi) 1995-10-19
FI954986A0 FI954986A0 (fi) 1995-10-19
FI116120B true FI116120B (fi) 2005-09-30

Family

ID=25925049

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954986A FI116120B (fi) 1993-04-20 1995-10-19 Uusi menetelmä suun kautta annettavien, syklosporiinia sisältävien farmaseuttisten valmisteiden valmistamiseksi

Country Status (13)

Country Link
EP (1) EP0697881B2 (cs)
JP (2) JP3862273B2 (cs)
AT (1) ATE218878T1 (cs)
CA (1) CA2161143A1 (cs)
CZ (1) CZ291237B6 (cs)
DK (1) DK0697881T3 (cs)
ES (1) ES2178653T3 (cs)
FI (1) FI116120B (cs)
HU (1) HUT72738A (cs)
NO (1) NO321076B1 (cs)
PT (1) PT697881E (cs)
SK (1) SK283442B6 (cs)
WO (1) WO1994023733A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
DE19545043A1 (de) * 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
CZ295207B6 (cs) * 1997-01-30 2005-06-15 Novartis Ag Tvrdá želatinová tobolka obsahující cyklosporin A
TR199902199T2 (xx) * 1997-03-12 2002-06-21 Abbott Laboratories Siklosporin tatbiki i�in hidrofilik ikili sistemler.
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
AU743098B2 (en) 1997-12-10 2002-01-17 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
US6207179B1 (en) 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
ATE425178T1 (de) 2001-10-19 2009-03-15 Isotechnika Inc Synthese von cyclosporinanalogen
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US7682433B2 (en) 2007-05-11 2010-03-23 Canon Kabushiki Kaisha Ink set, ink jet recording method, ink cartridge, recording unit, and ink jet recording apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
GB8903804D0 (en) † 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
EP0365044A3 (en) * 1984-08-02 1990-08-22 Sandoz Ag Novel pharmaceutical use of (nva)2-cyclosporine
AU609242B2 (en) † 1988-01-29 1991-04-26 Novartis Ag Cyclosporin compositions
GB2222770B (en) † 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CH679277A5 (cs) * 1989-02-09 1992-01-31 Sandoz Ag

Also Published As

Publication number Publication date
ES2178653T3 (es) 2003-01-01
FI954986A (fi) 1995-10-19
SK129895A3 (en) 1997-02-05
JP2006206615A (ja) 2006-08-10
WO1994023733A1 (de) 1994-10-27
FI954986A0 (fi) 1995-10-19
NO954152D0 (no) 1995-10-18
NO321076B1 (no) 2006-03-13
JPH08508984A (ja) 1996-09-24
DK0697881T3 (da) 2002-10-07
EP0697881A1 (de) 1996-02-28
EP0697881B2 (de) 2009-05-06
PT697881E (pt) 2002-10-31
SK283442B6 (sk) 2003-07-01
NO954152L (no) 1995-10-18
HUT72738A (en) 1996-05-28
CZ291237B6 (cs) 2003-01-15
CA2161143A1 (en) 1994-10-27
ATE218878T1 (de) 2002-06-15
JP3862273B2 (ja) 2006-12-27
CZ272995A3 (en) 1996-02-14
EP0697881B1 (de) 2002-06-12
HU9503019D0 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
FI116120B (fi) Uusi menetelmä suun kautta annettavien, syklosporiinia sisältävien farmaseuttisten valmisteiden valmistamiseksi
EP1039893B1 (en) Pharmaceutical compositions containing an omega-3 fatty acid oil
RU2257917C2 (ru) Самоэмульгирующиеся композиции для плохорастворимых в воде лекарственных препаратов
CN1150889C (zh) 水飞蓟素的口服微乳剂组合物
AU2002361701A1 (en) Pharmaceutical compositons of orally active taxane derivatives having enhanced bioavailability
CN1128671A (zh) 含环孢菌素的软胶囊组合物
CN1180840C (zh) 含有环孢菌素的软胶囊制剂
CZ20014214A3 (cs) Cyklosporinové prostředky v podstatě prosté oleje
RU2279894C2 (ru) Фармацевтические композиции для перорального и местного применения
US5958876A (en) Cyclosporin-containing pharmaceutical compositions
KR19990077360A (ko) 사이클로스포린 제제
EP1413297B1 (en) Cyclosporin-containing preparations
US20030211983A1 (en) Pharmaceutical preparations comprising cyclosporin for oral administration
CA2249675A1 (en) A novel composition containing cyclosporin
RU99114019A (ru) Фармацевтические композиции, содержащие производные n-сульфонилиндолина
US6352718B1 (en) Vasopressin antagonist formulation and process
AU3043400A (en) Cyclosporin solution
AU7615000A (en) Vasopressin antagonist formulation and process
JP2000514831A (ja) 医薬用組成物
KR0163210B1 (ko) 사이클로스포린 함유 액제 조성물
MXPA02000805A (en) Preserved pharmaceutical formulations

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 116120

Country of ref document: FI